Flat Preloader Icon
Skip to main content

OUR COMPANY

We develop and manufacture cannabinoid-based pharmaceutical products, complying with the highest quality standards and international regulations.

We operate under GMP certifications from INVIMA and ANVISA, ensuring safe and effective products tailored to the strict requirements of highly regulated markets like Brazil, Europe, and Australia.

We specialize in the production of active ingredients and finished products for highly regulated markets, focusing on chronic pain, anxiety, and neurological disorders. Our model combines clinical research, pharmaceutical development, and specialized manufacturing, ensuring that each product is backed by science and regulatory compliance.

We work closely with B2B partners, the medical community, and pharmaceutical companies to deliver innovative therapies to patients worldwide. From development to large-scale production, we adapt to the needs of each project, ensuring impactful and effective health solutions.

See products and services
Vision

We aim to become the largest cannabis pharmaceutical company in Latin America, offering various natural solutions that provide wellness to all.

We focus on clinical research, pharmaceutical development, and manufacturing under GMP certifications (INVIMA and ANVISA) to ensure the safety, efficacy, and regulatory compliance of our products.

We collaborate with research centers, regulators, and healthcare professionals to advance cutting-edge therapies, ensuring every treatment is supported by scientific evidence and meets the highest global quality standards.

Medical advisors
Quality assurance